INGN - Inogen: Improving But Still Struggling For Air

2024-07-01 06:37:42 ET

Summary

• Inogen aims to help millions suffering from COPD with portable oxygen delivery machines, but its financial performance has been inconsistent.
• Inogen faced execution issues, but recent improvements in operating momentum due to competitor exits and new management team are sparking optimism.
• Recent revenue growth, cost cuts, and narrowing losses are encouraging, but shares remain highly speculative and further progress is needed for a more positive outlook.

In the fall of 2022, I believed that there was little breathing room for investors in Inogen ( INGN ) . I considered shares to be a long-term growth story, facing real execution issues, leaving few green shoots to ignite optimism....

For further details see: